Admission hyperglycemia and adverse outcomes in diabetic and non-diabetic patients with non-ST-elevation myocardial infarction undergoing percutaneous coronary intervention.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28056793)

Published in BMC Cardiovasc Disord on January 05, 2017

Authors

Yuanyuan Hao1, Qun Lu1, Tao Li1, Guodong Yang1, Peijing Hu1, Aiqun Ma2,3,4

Author Affiliations

1: Department of Cardiovascular Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
2: Department of Cardiovascular Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. 15289366123@163.com.
3: Shaanxi Key Laboratory of Molecular Cardiology (Xi'an Jiaotong University), Xi'an, China. 15289366123@163.com.
4: Key Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education, Xi'an, China. 15289366123@163.com.

Articles cited by this

Standards of medical care in diabetes--2013. Diabetes Care (2013) 24.85

Diagnosis and classification of diabetes mellitus. Diabetes Care (2012) 9.03

Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet (2000) 8.46

Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation (2002) 6.26

Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet (2002) 5.77

Retracted Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation (2002) 4.30

Diabetes and mortality following acute coronary syndromes. JAMA (2007) 4.09

Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med (2004) 3.26

Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation (2008) 3.19

Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J (2006) 3.14

Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J (2005) 2.71

Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation (2005) 2.69

Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation (2008) 2.65

Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarction. Circulation (2009) 1.99

Impact of acute hyperglycemia on myocardial infarct size, area at risk, and salvage in patients with STEMI and the association with exenatide treatment: results from a randomized study. Diabetes (2014) 1.56

Association of stress hyperglycemia and atrial fibrillation in myocardial infarction. Wien Klin Wochenschr (2008) 1.51

Blood glucose level on admission determines in-hospital and long-term mortality in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock treated with percutaneous coronary intervention. Kardiol Pol (2010) 1.42

Acute hyperglycaemia: a 'new' risk factor during myocardial infarction. Eur Heart J (2004) 1.13

Prognostic value of admission glucose in non-diabetic patients with myocardial infarction. Am Heart J (2004) 1.10

Comparison of treatment and outcome of acute coronary syndrome in patients with versus patients without diabetes mellitus. Am J Cardiol (2009) 1.07

Glutathione reverses systemic hemodynamic changes induced by acute hyperglycemia in healthy subjects. Am J Physiol (1995) 1.06

Acute hyperglycemia in patients with acute myocardial infarction. Circ J (2012) 1.05

Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat. Acta Diabetol (2001) 1.03

Repetitive postprandial hyperglycemia increases cardiac ischemia/reperfusion injury: prevention by the alpha-glucosidase inhibitor acarbose. FASEB J (2005) 0.95

Impact of hyperglycemia in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: the HORIZONS-AMI trial. Int J Cardiol (2012) 0.95

Association of blood glucose with angiographic and clinical outcomes among patients with ST-segment elevation myocardial infarction (from the CLARITY-TIMI-28 study). Am J Cardiol (2007) 0.94

Glycaemic control in acute coronary syndromes: prognostic value and therapeutic options. Eur Heart J (2010) 0.85

Admission glucose level and in-hospital outcomes in diabetic and non-diabetic patients with ST-elevation acute myocardial infarction. Intern Med (2011) 0.82

Admission hyperglycemia predicts poorer short- and long-term outcomes after primary percutaneous coronary intervention for ST-elevation myocardial infarction. J Diabetes Investig (2013) 0.82

One-year mortality in elderly adults with non-ST-elevation acute coronary syndrome: effect of diabetic status and admission hyperglycemia. J Am Geriatr Soc (2014) 0.82

Prognostic impact of admission blood glucose for all-cause mortality in patients with acute coronary syndromes: added value on top of GRACE risk score. Eur Heart J Acute Cardiovasc Care (2014) 0.82

Impact of low level of high-density lipoprotein-cholesterol sampled in overnight fasting state on the clinical outcomes in patients with acute myocardial infarction (difference between ST-segment and non-ST-segment-elevation myocardial infarction). J Cardiol (2014) 0.81

Initial serum glucose level and white blood cell predict ventricular arrhythmia after first acute myocardial infarction. Am J Emerg Med (2010) 0.79